We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

3396:HKEXLegend Holdings Corporation Class H Analysis

Data as of 2026-06-12 - not real-time

HK$15.28

Latest Price

7/10Risk

Risk Level: Medium

Executive Summary

Legend Holdings trades at HK$15.28, comfortably above its 20‑day SMA of 14.08 and the 50‑day SMA of 11.28, confirming a bullish price trend. The 14‑day RSI sits at 60, indicating momentum but no imminent overbought condition, while the MACD histogram is slightly negative, hinting at a short‑term bearish crossover. Volatility is exceptionally high at 89 % over the past 30 days and the beta of 0.82 suggests the stock moves somewhat less than the market, adding to the risk profile. Valuation metrics are mixed: the trailing P/E of 41.3 exceeds the industry average of 36.5, yet the forward P/E of 9.5 and a price‑to‑book of 0.55 point to potential upside. The dividend yield is modest at 0.73 % with a zero payout ratio, raising questions about sustainability. With support around 9.67 and resistance near 18.64, the stock remains well above its key support but faces a sizable upside gap.
The company’s revenue has contracted by 9.7 % year‑over‑year, and margins are thin, underscoring earnings pressure. However, its diversified portfolio—spanning technology, financial services, agriculture, and real estate—provides multiple avenues for recovery. The decreasing volume trend may limit short‑term liquidity, while the “Extreme Greed” market sentiment (fear‑greed index 86.7) could inflate price expectations. Given the blend of bullish technical signals, attractive forward valuation, and substantial sector‑specific risks, investors should adopt a cautiously optimistic stance.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • Price above short‑term moving averages
  • MACD bearish histogram signal
  • Decreasing volume trend

Medium Term

1–3 years
Positive
Model confidence: 7/10

Key Factors

  • Forward P/E around 9.5 suggests upside
  • Low price‑to‑book ratio
  • Diversified business segments offering earnings recovery potential

Long Term

> 3 years
Neutral
Model confidence: 5/10

Key Factors

  • Broad diversification across sectors
  • Persistent revenue decline and thin margins
  • Regulatory and geopolitical exposure in China

Key Metrics & Analysis

Financial Health

Revenue Growth-9.70%
Profit Margin1.31%
P/E Ratio41.3
P/B Ratio0.5
Industry P/E36.5

Technical Analysis

TrendBullish
RSI60.0
SupportHK$9.67
ResistanceHK$18.64
MA 20HK$14.08
MA 50HK$11.28
MA 200HK$10.09
MACDBearish
VolumeDecreasing
Fear & Greed Index86.71

Valuation

Target PriceHK$13.11
Upside/Downside-14.20%
GradeFair
TypeValue
Dividend Yield0.73%

Risk Assessment

Beta0.82
Volatility89.19%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskMedium
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.